These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26886417)

  • 1. Insulin Resistance and a Long, Strange Trip.
    Semenkovich CF
    N Engl J Med; 2016 Apr; 374(14):1378-9. PubMed ID: 26886417
    [No Abstract]   [Full Text] [Related]  

  • 2. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    Hu K; Xu W; Williams Z
    N Engl J Med; 2016 Aug; 375(7):703-4. PubMed ID: 27532848
    [No Abstract]   [Full Text] [Related]  

  • 3. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    Doehner W; Anker SD
    N Engl J Med; 2016 Aug; 375(7):703. PubMed ID: 27532847
    [No Abstract]   [Full Text] [Related]  

  • 4. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    Bursztyn M
    N Engl J Med; 2016 Aug; 375(7):702-3. PubMed ID: 27532846
    [No Abstract]   [Full Text] [Related]  

  • 5. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    Viscoli CM; Kernan WN; Young LH
    N Engl J Med; 2016 Aug; 375(7):704. PubMed ID: 27532845
    [No Abstract]   [Full Text] [Related]  

  • 6. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    Kernan WN; Viscoli CM; Furie KL; Young LH; Inzucchi SE; Gorman M; Guarino PD; Lovejoy AM; Peduzzi PN; Conwit R; Brass LM; Schwartz GG; Adams HP; Berger L; Carolei A; Clark W; Coull B; Ford GA; Kleindorfer D; O'Leary JR; Parsons MW; Ringleb P; Sen S; Spence JD; Tanne D; Wang D; Winder TR;
    N Engl J Med; 2016 Apr; 374(14):1321-31. PubMed ID: 26886418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IRIS (Insulin Resistance Intervention after Stroke) trial: A new perspective on pioglitazone.
    Inzucchi SE; Furie KL
    J Diabetes; 2016 Sep; 8(5):607-9. PubMed ID: 27125599
    [No Abstract]   [Full Text] [Related]  

  • 8. Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial.
    Viscoli CM; Inzucchi SE; Young LH; Insogna KL; Conwit R; Furie KL; Gorman M; Kelly MA; Lovejoy AM; Kernan WN;
    J Clin Endocrinol Metab; 2017 Mar; 102(3):914-922. PubMed ID: 27935736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke.
    Kernan WN; Inzucchi SE; Viscoli CM; Brass LM; Bravata DM; Shulman GI; McVeety JC; Horwitz RI
    Stroke; 2003 Jun; 34(6):1431-6. PubMed ID: 12730556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial.
    Furie KL; Viscoli CM; Gorman M; Ford GA; Young LH; Inzucchi SE; Guarino PD; Lovejoy AM; Conwit R; Tanne D; Kernan WN;
    J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):21-27. PubMed ID: 28939682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone and bladder cancer.
    Ryder RE
    Lancet; 2011 Oct; 378(9802):1544; author reply 1544-5. PubMed ID: 22035551
    [No Abstract]   [Full Text] [Related]  

  • 12. Pioglitazone and bladder cancer.
    Hillaire-Buys D; Faillie JL; Montastruc JL
    Lancet; 2011 Oct; 378(9802):1543-4; author reply 1544-5. PubMed ID: 22035550
    [No Abstract]   [Full Text] [Related]  

  • 13. Pioglitazone may reduce cardiovascular events in high risk patients with prediabetes.
    Mayor S
    BMJ; 2016 Feb; 352():i1029. PubMed ID: 26896321
    [No Abstract]   [Full Text] [Related]  

  • 14. The PROactive study: some answers, many questions.
    Yki-Järvinen H
    Lancet; 2005 Oct; 366(9493):1241-2. PubMed ID: 16214581
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary: the PROactive study--the glass is half full.
    Fonseca V; Jawa A; Asnani S
    J Clin Endocrinol Metab; 2006 Jan; 91(1):25-7. PubMed ID: 16303829
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
    MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
    [No Abstract]   [Full Text] [Related]  

  • 17. [Infarct prevention for diabetics. To lower blood sugar is not enough].
    MMW Fortschr Med; 2001 Nov; 143(46):61. PubMed ID: 11759608
    [No Abstract]   [Full Text] [Related]  

  • 18. Which Patients With Ischemic Stroke and Insulin Resistance May Benefit From Pioglitazone Hydrochloride?
    Hankey GJ
    JAMA Neurol; 2017 Nov; 74(11):1294-1296. PubMed ID: 28975238
    [No Abstract]   [Full Text] [Related]  

  • 19. PROactive in patients with type 2 diabetes and previous myocardial infarction: swinging the sword of Damocles?
    Westerbacka J
    J Am Coll Cardiol; 2007 May; 49(17):1781-2. PubMed ID: 17466228
    [No Abstract]   [Full Text] [Related]  

  • 20. A perspective on coronary revascularization in the PROactive 05 study.
    Riche DM; Dale KM
    J Am Coll Cardiol; 2007 Oct; 50(17):1705-6; author reply 1706. PubMed ID: 17950157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.